US 9308182
Parenteral formulations of rasagiline
granted A61KA61K31/135A61K9/0004
Quick answer
US patent 9308182 (Parenteral formulations of rasagiline) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- TEVA PHARMACEUTICAL INDUSTRIES, LTD.
- Grant date
- Tue Apr 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/135, A61K9/0004, A61K9/0019, A61P